LVS CEO exercises $3.2M options near 52-week high amid Macau recovery

Patrick Dumont sold $3.2M in Las Vegas Sands shares in what appears to be a discretionary transaction rather than a 10b5-1 plan. The stock trades at $54.05, well off its 52-week high of $70 but above the $30 low, despite being down 17% year-to-date. The timing is given the stock's recent pullback from peak levels earlier this year.

The sale comes as casino operators face intensifying pressure in Macau, where gaming revenues remain volatile amid shifting regulatory dynamics and uneven travel recovery from mainland China. Las Vegas Sands derives roughly two-thirds of its revenue from Macau properties, making it particularly exposed to this uncertainty. An inside seller taking chips off the table at current levels, with the stock already down nearly 20% from its high, suggests the executive sees more downside risk than the market is pricing in.

AMETEK CEO buys $2.5M near 52-week highs despite flat year

CEO Zapico bought $2.5M of AME at $211, well above the 52-week low of $145 but off the $242 peak. The industrial manufacturer trades near the middle of its range after a modest YTD gain, suggesting this is a tactical add rather than a distressed rescue. Zapico has historically bought during pullbacks that preceded double-digit gains within six months.

AMETEK CFO buys $804K near 52-week high amid industrials rally

EVP Dalip Puri bought $804K of Ametek at $211, adding to a position after the stock pulled back 13% from its $242 high. The industrial conglomerate trades near the middle of its range despite strong margins in its aerospace and process instrumentation units. Puri last purchased shares in 2022 before a 40% advance over the following year.

TransDigm director exits $516K at 52-week low after 26% drop

Chief Howley unloaded $516K of TransDigm at $1,192, just $15 above the 52-week low. The aerospace parts maker trades at a 27% discount from its peak despite healthy airline traffic, suggesting margin pressure from contract renegotiations. Insider selling near multi-month lows typically precedes weaker guidance.

Arista CTO sells $488K near 52-week high amid AI networking boom

Director Kenneth Duda sold $488K of ANET stock at $136, just 18% below its all-time high of $165. The networking equipment maker has more than doubled from its 52-week low as AI data center buildouts drive demand for its switches. Insiders typically sell near peaks when they believe upside has narrowed.

Incyte R&D chief exercises $438K as stock nears 52-week high

Chief Medical Officer Cagnoni bought $438K of INCY at $92.95, adding to his position as the stock trades 17% below its 52-week high. The biotech has pulled back from November peaks despite recent regulatory wins for its dermatology portfolio. Cagnoni's timing comes ahead of pivotal data readouts for the company's inflammatory disease pipeline.